View Author
patient nerve leprosy nerve function impairment month reaction event registration treatment group function study impairment trial nerve damage corticosteroids prednisolone mb patients period follow-up damage type 1 reaction participant placebo incidence lepr rev outcome 2 years figure observation period result type 1 reactions regimen cohort placebo group duration type 2 reaction int j lepr improvement type 2 reactions analysis 6 months pb patients bangladesh leprosy patients corticosteroid review therapy number randomised observation effect 6 months duration nicholls pg mycobact dis prednisolone group difference motor course 12 months survival curves 60 months nerve pain type 1 incidence rates 5 years 1 year van veen richardu leprosy group control cochrane nerve function 36 months neuritis episode 100 pyar smith corticosteroid regimens prednisolone treatment
2 Most Recent Publications
|
Corticosteroids for treating nerve damage in leprosy. A Cochrane review.
(Article)
Veen, N.H.J. van Nicholls, P.G. Smith, W.C.S. Richardus, J.H. |
2009-06-02
|
|
Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up.
(Article)
Richardus, J.H. Nicholls, P.G. Croft, R.P. Withington, S.G. Smith, W.C.S. |
2004-04-01
|